Deciphera Pharmaceuticals, part of the ONO Group, is a biopharmaceutical company dedicated to discovering and developing innovative medicines for cancer patients. Utilizing its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology, Deciphera aims to improve patient lives through a broad portfolio of cutting-edge treatments.
The Vice President, US Market Access is responsible for developing and executing the market access strategy to ensure patients, providers, and payers have access to the company's rare oncology therapies and future specialty products. This role leads a team of professionals and serves as a key member of the US Commercial Leadership Team.
Deciphera Pharmaceuticals, part of the ONO Group, is a biopharmaceutical company dedicated to discovering and developing innovative medicines for cancer patients. Utilizing its proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology, Deciphera aims to improve patient lives through a broad portfolio of cutting-edge treatments.
Olema Oncology